These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4397439)

  • 1. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial using the beta receptor blockader Visken].
    Szám I; Holló J
    Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 5. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol].
    Moccetti T; Halter J; Lichtlen P
    Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of alprenolol in the treatment of angina pectoris].
    Lippenholtz A; Talmasky S; Berconsky I
    Prensa Med Argent; 1969 Sep; 56(27):1357-61. PubMed ID: 4391256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-blocking agents in angina pectoris. A double-blind trial].
    Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Decrease in ventricular frequency in auricular fibrillation using Visken].
    Bender F; Dürholz HH; Gradaus D; Schmidt E
    Med Welt; 1971 Feb; 9():340-1. PubMed ID: 4396541
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with the preparation "Visken" (beta blocking agent) in angina pectoris].
    Mihail A; Popescu P; Petrescu X; Popa N
    Med Interna (Bucur); 1972 Aug; 24(8):925-32. PubMed ID: 4404181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T; Aquaro G
    Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients].
    Saner R
    Therapie; 1970; 25(2):393-501. PubMed ID: 4403159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
    Scebat L; Bensaid J
    Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H; Ducloux G
    Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
    Gasparotto G; Pagnan A
    Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
    [No Abstract]   [Full Text] [Related]  

  • 19. A monitored release study. A clinical trial of oxprenolol in general practice.
    Forrest WA
    Practitioner; 1972 Mar; 208(245):412-6. PubMed ID: 4402044
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
    Mihail A; Popescu P; Ioan A; Bruckner I; Paraschiv A; Petrescu X; Popa N
    Med Interna (Bucur); 1973 Jan; 25(1):87-93. PubMed ID: 4144020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.